Published in AIDS Weekly and Law, December 6th, 2007
"Using this model, we altered the residues predicted to be exposed on the surface of this globular structure. Most of the alanine substitutions in these residues exerted little effect on the antiretroviral activity of human TRIM5c alpha(hu). or rhesus monkey TRIM5C alpha(rh). However, alteration of arginine 119 of TRIM5 alpha(hu). or the corresponding arginine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.